BioGene Therapeutics Inc. — Form D
BioGene Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-08-06. The offering totals $250K, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-08-06
- Form: D
- Accession: 0002140719-26-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Revenue range: Decline to Disclose
- SEC file number: 021-593351
Issuer
- Name: BioGene Therapeutics Inc.
- CIK: 0002140719
- Entity type: Corporation
- Jurisdiction: TEXAS
- Address: 5900 BALCONES DR, STE 100, AUSTIN, TX, 78731
- Phone: 1-512-379-7526
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Tyronne Howton | Related Person | AUSTIN, TX |
| Stephen Van Deventer | Related Person | AUSTIN, TX |
| DEEPAK SAMPATH | Related Person | AUSTIN, TX |
| PATROSKI LAWSON | Related Person | AUSTIN, TX |
| STEVE GLOVER | Related Person | AUSTIN, TX |
| RAJ PRUTHI | Related Person | AUSTIN, TX |
Other filings by this issuer (4)
More